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ABSTRACT
BACKGROUND: Every year tuberculosis causes over 10 million cases globally and in
recent years has caused over 9,000 cases annually in the United States. TB can be
transmitted in hospital settings, and South Carolina hospitals, like hospitals elsewhere in
the country, maintain a responsibility to test their employees for this disease. Nosocomial
infections of active TB among patients and healthcare workers can be burdensome on
hospital resources. Testing healthcare workers and implementing prevention strategies are
examples of administrative controls provided in the 2005 guidelines by the Centers for
Disease Control and Prevention (CDC). Implementation of administrative controls are
considered the most important and are the first tier of the hierarchical control strategies for
preventing TB transmission in healthcare settings.
OBJECTIVE: The purpose of this study was to review current employee TB screening
practices in South Carolina hospitals, in particular to assess (i) whether they screen using
the traditional tuberculin skin test or the newer Interferon Gamma Release Assay; and (ii)
whether they have (or have not) performed a formal TB risk assessment following
suggested administrative prevention controls from guidelines by the CDC.
METHODS: Utilizing the TB Risk Assessment for healthcare facilities, a questionnaire
was designed and distributed via Survey Monkey with the assistance of the South Carolina
Hospital Association (SCHA) to member South Carolina healthcare facilities (n=100).
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RESULTS: Fifty-one health care facilities participated in the study. Forty-one facilities
(84%) reported using the guidelines as a basis for employee TB testing, yet only thirty-four
facilities (68%) stated that a formal risk assessment had been performed prior to the survey.
CONCLUSION: The majority of South Carolina hospitals surveyed are adhering to CDC
testing guidelines for healthcare employees and conducting a formal risk assessment.
Additional training and guidance with all hospital employees would be beneficial in
providing consistency of policy implementation across the state. Implementation of
administrative controls is critical in preventing TB transmission in hospitals.
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CHAPTER 1
INTRODUCTION
Section 1.1: Statement of the Problem
Global TB incidence in 2017 was 130 cases per 100,000 (The World Health
Organization 2018). The number of new cases in the United States was 2.9 per 100,000
persons (CDC 2018). At the local level, South Carolina reported 2 new cases per 100,000
of tuberculosis in the state in 2017 (SCDHEC 2018). Although prior to 2009, South
Carolina TB incidence rates were greater than the national TB incidence rates, recent data
show the reverse to be true (Arden 2013) [Figure 1.1].
Infections spread in healthcare settings require not only time and investigation but also
tracking and treating those possibly infected. This can become especially difficult when a
healthcare facility is in a large metropolitan area in which the population (including
healthcare workers and patients) is continually changing. Nosocomial TB infections which
are latent or present asymptomatically can be burdensome on patients, healthcare workers,
and resources.
Historically, occupational exposure among US healthcare workers placed them at
higher risk for TB disease and LTBI; however, recent data suggest that like TB rates in the
general population, rates among healthcare workers have also declined. (MMWR 2019).
In fact, the incidence rates among healthcare workers are similar to the general population.
Similarly, a study by Mongkolrattanothai et al found no difference in incidence rates
between U. S. healthcare workers and the general population but reported
1

significant differences in the incidence rates between foreign- born healthcare workers
(10.8 cases per 100,000) and US born healthcare workers (0.8 new cases per 100,000)
(2019).
While, there have been no reported cases of TB exposure or transmission in South
Carolina healthcare facilities in recent years, TB investigations in Greenwood, Rock Hill,
and Charleston school districts have resulted in the discovery of at least 2 cases of active
TB. High profile incidents of tuberculosis exposure in health care facilities in New York
and Texas also emphasized the need to assess guidelines provided to healthcare facilities
to prevent transmission of the disease among healthcare patients and workers.
Section 1.2 Purpose of the Study
The purpose of this study is to describe global, national, and local TB incidence and to
assess the utilization of administrative controls outlined in the CDC 2005 guidelines by
healthcare facilities in South Carolina hospitals. Administrative controls reduce the risk of
exposure to infectious TB. These preventive measures include but are not limited to
establishing and implementing an infection control program, educating, training, and
counseling personnel, patients, and visitors about TB, screening staff, and conducting a
risk assessment of the facility. This study focused specifically on the following
administrative controls: hospital TB screening tests, hospital employee TB screening
procedures, and completion of a hospital risk assessment. Evaluating these administrative
controls could have implications to re-evaluate current recommendations and to modify
recommendations to reduce unnecessary testing of healthcare workers.
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CHAPTER 2
LITERATURE REVIEW
Mycobacterium tuberculosis (MTB), a tubercle bacilli, is the causal agent for
tuberculosis (TB). The mycobacterium is resistant to drying and water-based bacterial
agents. TB is an airborne disease spread through droplet nuclei from an infectious person
and is transmitted primarily through the respiratory tract, although it can also enter the
body through mucous membranes and breaks in the skin (Belknap and Daley 2014).
Clinical manifestations of TB are presented in three forms: pulmonary, extra pulmonary,
and miliary. Pulmonary TB is found in 80% of cases which occur in immunocompetent
persons. Symptoms include chest pain, productive cough with or without a bloody sputum,
anorexia, fatigue, fever, and chills. Extrapulmonary TB is common in children and
immunocompromised persons, and the symptoms are fatigue, night sweats, and issues with
the organ system infected. Miliary TB is also found in children and the immunosuppressed;
it essentially produces small nodules that infect every organ.
Symptoms of miliary TB are also dependent upon the organs affected in the body.
Although TB usually affects the lungs, any tissue or organ of the body (i.e. spine, lymph
nodes, heart, or brain) (Golub et al, 2014) may be infected. Once bacteria-laden droplet
nuclei reach the alveoli of the lungs, multiplication occur causing latent tuberculosis
infection and tuberculosis disease. Latent tuberculosis infection (LTBI) refers to being
infected with TB bacteria but the body’s immune system prevents sickness and
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infectiousness from occurring in an individual. If the body discontinues fighting the
bacteria, the bacteria can multiply, and the individual can develop TB disease.
Currently, the tuberculin skin test (TST) and interferon gamma release assays (IGRAs)
are used for routine screening for LTBI. TST and IGRAs are also used in conjunction with
chest x-rays and sputum collection to test for TB infection in patients being evaluated for
LTBI or the actual disease. Treatment of all three forms of TB disease consists of treatment
in two phases with a combination of isoniazid, rifampin, pyrazinamide, and ethambutol for
6 to 9 months [Table 2.1] . Observation of each dose of medication, also known as directly
observed therapy (DOT) is the now universally recognized as the “standard of care” for
treatment of TB disease. In 1921, tuberculosis became one of the first diseases to have a
vaccine. The vaccine, created by Albert Calmette and Camille Guérin named Bacillus
Calmette-Guérin or BCG, was used quite commonly in Europe to lessen the burden of the
disease (Golub, Coberly, & Chaisson, 2014). BCG is still used in many developing
countries today to vaccinate infants and healthcare workers.
Section 2.2 Screening Tests
Many of the signs and symptoms of TB disease are nonspecific, and LTBI is
asymptomatic, which makes diagnosing TB reliant on screening test to identify those who
have disease. Multiple screening tests have been developed over the years, and some
screening tests have been used at the same time. Current screening tests include a) the
tuberculin skin test (TST), b) Quantiferon Gold Intube (QFT-GIT), c) and T-spot. The
sensitivity and specificity of these tests, as documented by the CDC, are provided in Table
2.2 (MMWR 2010). There are two variations of the TST test, one-step TST and the twostep TST. The two-step TST is used to test new employees that will be tested periodically
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for TB infection. Two-step TST screening requires persons who test negative during first
TST to then have another TST test. While the single or one-step TST test, is the one-time
injection of PPD and then a follow-up visit to have the test read.
Several factors affect the agreement of these tests including test interpretation criteria,
prevalence of infection, prior BCG vaccination, and co-infection of other diseases.
Some health care facilities use IGRAS in serial testing of workers since CDC guidelines
state that in all circumstances in which TST is the current testing method, IGRAS can be
substituted in place of the TST. However, serial testing health care workers in low
incidence areas with IGRAS results in a decrease in the predictive value of a positive test
(Slater 2013). With the availability of multiple tests for screening, deciding which test to
utilize can add to the complexity of screening healthcare workers.
Section 2.3: Tuberculosis in Healthcare Settings
Hospitals in the U.S. have experienced TB transmission from healthcare workers
to patients. TB transmission occurred in 2003 in the maternity ward and nursery at a New
York hospital. Approximately 1500 patients were exposed to infectious pulmonary TB
disease by a foreign-born nurse who had been diagnosed with latent TB infection but
refused treatment (MMWR 2005). The majority of those exposed could not be located for
testing, but it was found that four infants had positive TST results (2005). In Texas in 2014,
over 700 infants and 40 employees were exposed to TB by a nurse with TB disease working
in an El-Paso hospital. Subsequent testing found five babies tested positive for TB. It was
later found that four of the five babies who tested positive were also vaccinated with BCG,
which may have resulted in false positives (Bailey 2014).
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Section 2.4: South Carolina Hospital Association
Created to set and reach appropriate standards of care, the South Carolina Hospital
Association (SCHA) aims to keep patients in the state safe and healthy. SCHA is a private
non-profit organization comprised of 100 member hospitals and health systems (e.g.
substance abuse centers). Member healthcare facilities range in size from 14 beds to 864
beds. As of 2018, there are 104 hospitals in the state.
Section 2.5: CDC TB Transmission Guidelines
‘Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in
Health-Care Settings, 2005’, the TB transmission guidelines for healthcare facilities
published by the CDC, were a result of several factors (MMWR 2005). Previous guidelines
issued first in 1992 and updated in 1994 suggested controlling TB in healthcare facilities
through a risk assessment process that corresponded to environmental and respiratory
protection. Because of the successful implementation of the 1994 recommendations, TB
transmission within healthcare facilities declined.
The guidelines were restructured in 2005 to reflect the changing TB trends in the
US, changes in medical practice, and current understanding of the disease. The 2005 CDC
guidelines included updates to improve risk assessments, frequency and criteria for testing
of healthcare employees, and the types of facilities covered (MMWR 2005). The guidelines
provided recommendations primarily for inpatient facilities where healthcare is provided.
Divided into hierarchical tiers (administrative controls, environmental controls, and
respiratory-protection controls), the guidelines aimed to maintain momentum and to
eliminate the threat of nosocomial transmission. These controls were essential in the
reduction of TB transmission in health care facilities however notable differences in rates
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within geographic areas remained. Thus, depending upon the region, the risk associated
with tuberculosis transmission among health care workers would vary.
Per 2005 CDC guidelines, environmental controls consist of ventilation and
filtration in healthcare settings to control and to minimize the spread of infectious droplets,
and respiratory protection controls limit the risk of exposure in high risk situations through
respiratory equipment. This study focused on administrative controls (testing practices
specifically). The goal of administrative controls is to reduce the risk of TB infection
(MMWR 2005). Administrative controls include conducting facility risk assessments,
screening employees, and training employees.
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Table 2.1 Tuberculosis Treatment Regimens
Intensive Phase
Regimen Drugs

Continuation Phase

Interval
and Dose
(minimum
duration)
7
days/week
for 8 weeks
(56 doses)
Or
5
days/week
for 8 weeks
(40 doses)
7
days/week
for 8 weeks
Or
5
days/week
for 8 weeks

Drugs Interval and
Dose
(minimum
duration)
INH
7 days/week
RIF
for 18
weeks
Or
5 days/week
for 18
weeks

Comments

INH
RIF

3 times
weekly for
18 weeks

Preferred
alternative
regime in
situations in
which more
frequent DOT
during
continuation
phase is
difficult to
achieve
Use with
caution in
persons with
HIV and/or
cavitary
disease;
Missed doses
can lead to
relapse and
drug
resistance
Not for
persons with
HIV or
cavitary
disease;
Missed doses
= ineffective.

1

INH
RIF
PZA
EMB

2

INH
RIF
PZA
EMB

3

INH
RIF
PZA
EMB

3 times
weekly for
8 weeks

INH
RIF

3 times
weekly for
18 weeks

4

INH
RIF
PZA
EMB

7
days/week
for 14
doses then
twice
weekly for
12 doses

INH
RIF

Twice
weekly for
18 weeks
(36 doses)
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Preferred
regimen for
patients with
newly
diagnosed
pulmonary
TB.

Regimen
Effectiveness
Greater

Lesser

Table 2.2: Tuberculosis Screening Tests
Tests

Testing Process

Limitations

Tuberculin
Skin Test
(TST)

Injection of protein
purified derivative
(PPD)

Proper
1907
administration; Inter- (current
reader inaccuracy and method)
bias; Follow-up visit;
False positives due to
BCG and
nontuberculosis
mycobacteria contact

Quantiferon
TB (QFT)

ELISA measures
cell mediated
response of IFN-y
released in response
to PPD

Specificity less than
TST

2001(no
longer
available)

Quantiferon
TB Gold
(QFT-G)

Fresh whole blood
incubated with
controls and separate
peptides

Requires trained
clinicians and
laboratories to test;
Time sensitive

2005 (no
longer
available)

Quantiferon
Gold Intube
(QFT-GIT)

Special tubes with
control materials and
antigens to allow
direct testing of
fresh blood; IFN-y
measured in plasma

Varied interpretation
criteria in other
countries prior to US
FDA approval

T-Spot

PBMCs incubated
with controls and
peptides; ELISA
detects increase in
number of cells that
secrete IFN-y

Varied interpretation
criteria in other
countries prior to US
FDA approval
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Year
Available

SE

SP

95%

85%

2007

84%

99%

2008

91%

88%

CHAPTER 3
METHODS
In order to determine hospital compliance with the 2005 CDC TB guidelines, we
needed to contact all 100 health care facilities in South Carolina. We developed questions
for use as part of a questionnaire (Appendix A). Specifically, survey questions focused on
a) which employees were being screened for TB, b) the frequency of employee testing, and
c) whether the hospital had performed a risk assessment (Appendix B) in accordance with
the 2005 CDC guidelines. Initial draft of questions was from the risk assessment (Appendix
D). SCHA expressed concerns in regards privacy of facilities’ data and survey length. The
questions were redrafted and restructured to shorten the survey and address privacy whilst
still probing for the information that was of interest to the study. Six questions stemmed
from the TB risk assessment and 4 questions were the product of the study and the SCHA.
Facilities were also asked for suggestions or comments that would be beneficial for TB
control in the facility. Although the response rate was high (51%) , data were missing for
some questions.
We collaborated with the South Carolina Hospital Association (SCHA) in the
survey development and administration, because they were familiar to hospitals in South
Carolina and had greater access to this population. Once survey questions were developed,
the SCHA edited, formatted and organized the 11 questions into a questionnaire
administered via Survey Monkey®. The SCHA Director wrote a letter which accompanied
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our questionnaire, notifying the infection control employee completing the questionnaire
of the study purpose, how the information would be used, and that participation was
voluntary.

Survey Monkey® was used, because the SCHA had used this website

previously to collect information from hospitals. The survey was deployed in April 2015.
The data were compiled by the SCHA who provided the final data in an Excel spreadsheet.
A calculator was also developed in Microsoft Excel to calculate the specificity, sensitivity,
positive predictive value, negative predictive value, and kappa statistic from screening
data.
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CHAPTER 4
SOUTH CAROLINA HOSPITAL ASSOCIATION STUDY

BACKGROUND: Seven hundred babies were exposed to TB in a Texas hospital nursery by
a hospital employee from August 2013 to September 2014 (Arden 2013), and a nursery
and maternity ward in New York City in 2003 reported TB transmission from a nurse to 4
infants (Santora 2005). With Centers for Disease Control (CDC) guidelines to prevent TB
transmission in health care settings and advancements in testing, these isolated incidents
highlight a deficiency in infection control measures. Implementation of CDC guidelines
are important in sustaining the decline of TB in United States especially in South Carolina
which often historically ranked in the top ten states with the highest TB case rates.
PURPOSE: The purpose of this study is to determine the use of the Centers for Disease
Control and Prevention guidelines for preventing the transmission of Mycobacterium
tuberculosis in health-care settings, 2005 in South Carolina health-care facilities.
METHODS: A voluntary questionnaire was compiled in collaboration with the South
Carolina Hospital Association (SCHA) and administered via Survey Monkey by the
SCHA.
RESULTS: Fifty-one percent (51%) of member facilities of the South Carolina Hospital
Association completed the survey. Eighty-four percent of participating facilities were
aware of the CDC TB Risk Assessment Guidelines. Furthermore, sixty-eight percent of
responding facilities conducted formal risk assessments to assess the need for annual
employee
13

testing. Eighty percent of facilities thought periodic TB training for hospital staff would be
beneficial. Sixty-four percent facilities reported that outside assistance for didactic
informational sessions on infectious diseases for employees would be useful.
CONCLUSION: The majority of South Carolina healthcare facilities are currently
performing risk assessments and utilizing the CDC Risk Assessment Guidelines (2005) for
employee TB screening. Despite being classified as low risk facilities, there is continued
annual testing of all employees. This may be indicative of some difference in policy at
facility level and national level. A few facilities reported having policies issued to them
from outside sources. Implementing informational sessions for all employees regarding
TB and other infectious disease is not only desired by facilities but would also be beneficial
preventing nosocomial transmission.
BACKGROUND
Preventing nosocomial tuberculosis transmission through the screening of health care
workers is fundamental for infection control programs. The southern United States has
historically had high incidence rates of tuberculosis. South Carolina until 2009 had case
rates above the national case rate of TB (Arden 2013). The CDC has had guidelines for
the prevention of TB transmission but had to modify those guidelines in the 1994 due to a
resurgence of TB, lapses in infection control measures, and co-infection of HIV (MMWR
2005). Although there have been no recent TB outbreaks in a health care facility in South
Carolina there have been high profile exposure incidents in Texas and New York health
care facilities. A state that only recently fell below the national case rate is a relevant
concern, and TB control practices in health care settings should be assessed. The objective
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of this study was to assess SC health care facilities and their compliance with the 2005
CDC TB Guidelines.
METHODS
A survey was composed through a collaboration the South Carolina Hospital
Association. The survey was administered via Survey Monkey® and sent to 100 member
facilities of the South Carolina Hospital Association. Questions in the survey focused on
the facility’s current testing practices of employees and if the facility utilized the 2005
CDC Risk Assessment as a basis for the facility’s testing policies. Facilities were also asked
for suggestions or comments that would be beneficial for TB control in the facility.
RESULTS
Fifty-one-member facilities responded to the survey of thirteen questions that probe the
practices of South Carolina health care facilities. Thirty-four (68%) facilities reported
conducting formal TB risk assessments per the 2005 CDC guidelines for preventing
transmission in health care settings to assess whether all employees should be tested
annually for TB. Sixteen (31%) of the facilities did not or were not sure if their facility
conducted formal TB risk assessments. Although, 84% of the facilities stated that the CDC
guidelines was used as a basis for the facility’s TB policy. Nearly all respondents (91%)
test all employees for TB upon hire and only 2 (4%) facilities do not perform subsequent
testing of all employees citing that they are a low risk facility and deem annual testing of
all employees unnecessary.
TB screening tests utilized by facilities were also relatively the same with only a
few institutions using IGRAS solely for employee testing, although quite a few stated using
IGRAS for subsequent testing for employees with positive TSTs. Some facilities also stated
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using multiple tests for initial employee testing. Eleven facilities reported using the
traditional TST and confirming positives with an IGRA. Majority of subsequent annual
testing was performed using the TST and 69% of facilities reported subsequent annual
testing of all employees. More than half of the facilities (64%) believe additional assistance
would be useful training for employees on not only TB but other infectious diseases.
Surprisingly, the comments from facilities suggested a discord on the process for
when an employee tests positive for TB. Some facilities stated having layers of steps while
others only had a single step. One facility even stated that the steps would vary depending
on whether the employee was diagnosed with LTBI, TB disease, or was felt to have a false
positive test. Another facility noted that the guidelines that were adopted in their facility
regarding TB control were provided from a corporate office of advisors.
DISCUSSION
Most health care facilities in South Carolina are performing formal TB transmission
risk assessments per the 2005 CDC TB Guidelines. However, a few facilities were not or
were unsure if their facility had conducted a formal risk assessment. Although most
facilities followed up employees whose test results were positive with an IGRA and chest
x-ray, the order of testing varied from facility to facility. Due to variations among facilities,
it may prove beneficial to have a training or additional guidance at the state level for
consistency across the state.
Although the 2005 guidelines do not recommend serial testing of employees in low
risk settings, many facilities still conducted annual testing of all employees. This may be
the result of “tradition” in that they have always tested everyone annually or possibly the
fear of the consequence of not testing everyone yearly. Also, despite the TST’s low
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specificity, it is the most commonly used test for initial screenings and subsequent
screenings in South Carolina facilities. The wide usage of the TST is possibly due to budget
restraints of facilities as the TST is not as costly as the IGRAS.
Despite the 2005 guidelines recommendation of annual TB education for all
healthcare workers, 64% of

facilities indicated an interest in additional training for

employees for a variety of infectious diseases including TB. There were also some
questions unanswered by facilities which resulted in missing responses. The study is not
sure if nonresponse to some questions was due to the individual answering the questions
not knowing the response. This may be indicative of the possibility that the person the
study wanted to target (infection control personnel and employee health personnel) was
not the person responding to the survey.
Eliminating nonessential testing would be beneficial during the current nationwide
shortage of one of the TST antigens used for screening (MMWR 2019). Although IGRAS
can be used in place of the TST, 73% of SC hospitals reported using TST for annual
employee testing. Furthermore, recent data suggests that incidence rates of TB disease and
LTBI among healthcare workers are consistent with the incidence rates of the general
population. Thus, updates to the 2005 have been provided by CDC to limit employee
testing after baseline and the absence of on-going transmissions. Recommendations for
2019 include a personal risk assessment to be used in addition to the recommendations
provided in 2005 (MMWR 2019). While nosocomial TB transmission is not eradicated,
successful implementation of CDC 2005 guidelines has mitigated the threat. As the trends
are followed, guidelines will continue to be modified to prevent TB transmission and
protect hospital employees and patients.
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Additional research should be done with health care facilities outside of the SCHA
and with employee TB testing data to gain better representation of TB in health care
workers in South Carolina. These factors were significant in deciding to collaborate with
the organization however, some of the scope of the study was limited in that no
demographic information was collected, non-response to some questions, and only member
institutions of the SCHA were selected as participants.
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Table 4.1: TB Testing Practices in South Carolina Hospitals

Awareness of CDC Risk Assessment
Yes
No
Not Sure
Perform formal TB Risk Assessment
Yes
No
Not Sure
All employees tested upon hire
Yes
No
Not Sure
Ambulatory setting employee testing
Yes
No
Not Sure
Direct patient contact testing only
Yes
No
Not Sure
Initial screening test
Single TST only
Two-step TST only
Quantiferon only
T-spot only
TST and IGRA
Employees tested annually
All employees
Subset (high-risk) employees
Screening test used for annual testing
TST only
IGRA only
Periodic TB training
Yes
No
Not sure
Additional assistance useful
Yes
No

Frequency

Percentage

41
0
8

84

34
7
9

68
14
18

47
3
0

94
6

37
0
0

100

12
33
0

27
73

2
33
2
1
7

4
73
4
2
16

25
11

69
31

15

20
2

91
9

29

36
5
4

80
11
9

29
16

64
36

2

16

Percentages calculated upon response obtained. N = 51 total respondents.
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No
Response

1

1

14

6

6

6

5

CHAPTER 5
DISCUSSION
Advanced in TB infection detection and guidelines for preventing transmission in
health care settings have resulted in low risk for TB infection for health care workers in the
United States and in South Carolina. Until 2019, the CDC had not updated the 2005
guidelines for tuberculosis transmission in healthcare settings. Differences in sensitivity
and specificity of screening tests used to test hospital employees add to the complexity of
preventing TB transmissions in hospitals as some hospitals reported using multiple tests
within a facility. Serial testing with different tests can result in poor agreement among tests.
In addition, the CDC has updated tuberculosis screening guidelines of health care workers
in the United States [Appendix D]. While the new guidelines provide additional
recommendations for screening healthcare employees, much of the old guidelines are still
in effect. The new guidelines suggest the baseline testing of all healthcare workers in
addition to an individual risk assessment being performed to reduce number of subsequent
tests and not routinely screening workers without LTBI. Therefore, the new guidelines
provide additional support that the 2005 guidelines needed to be re-assessed and modified
to follow the trend of tuberculosis in healthcare facilities in the United States.
Furthermore, the CDC’s 2005 guidelines for preventing TB transmission in health
care facilities have been successful in preventing TB infection. With the new
recommendations set forth in the 2019 CDC guidelines may allow for allocation of
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resources for other purposes. Further research should seek to find whether healthcare
facilities have additional or different guidelines at

an institutional level and what

similarities, or differences exist between them and the national guidelines. Consistency is
key in order to prevent the spread of TB within the healthcare setting.
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APPENDIX A: THE SURVEY
The Arnold School of Public Health and the South Carolina Hospital Association, in a
collaborative effort to determine M. Tuberculosis testing policies of South Carolina
Hospital employees, request the participation of your facility.
All individual responses will be kept confidential and only aggregate data will be available.
If there are any questions or concerns that you would like addressed, please contact Dr.
Rick Foster of the South Carolina Hospital Association at rfoster@scha.org or (803) 7443538.
We thank you in advance for your participation.
1. Please fill out the information below.
Name of Person completing survey:
Name of Facility:
2. Please answer the questions below.
2a. Does your facility use the CDC Risk Assessment Recommendations published in the
MMWR of December 30, 2005 as the basis for its employee TB policy guidelines?
Yes No
Not sure
2b. Has your facility conducted a formal "TB Risk assessment" (as per the MMWR 2005
guidelines) to help assess whether TB testing does or does not need to be conducted
annually for all employees? Yes No
Not sure
3. Are all employees tested for TB when initially hired ?
Yes No
4. If your institution has physician clinics which are not hospital-based, do you require
employees in these ambulatory care settings to have initial and/or subsequent
annual TB testing?
Yes No
Not sure
5. Do you conduct initial or subsequent TB testing for employees only with direct
patient contact?
Yes No
5a. Please provide any additional comments if necessary.
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6.

How is you initial TB screening conducted? (select all that apply)
a. single "tuberculin skin test"?
b. 2-step" tuberculin skin testing?
c. Quantiferon Test (an IGRA test)?
d. T-Spot test (an IGRA test)?
e. traditional tuberculin skin test, and "positive tests" are then "confirmed with
one of the IGRA tests
7.
Annual Testing (select all that apply)
a.
Subsequent annual testing is done for all employees
b.
Subsequent annual testing is done just for a subset of employees (e.g. just
for "high-risk" employees)
c.
Subsequent annual testing is done with a traditional "tuberculin skin test"
d.
Subsequent annual testing is done just with the Quantiferon Test (an IGRA
test)
e.
S
ubsequent annual testing is done just with the T-Spot test (an IGRA test)
f.
Subsequent annual testing is done with a traditional tuberculin skin test, and
"positive tests" are then "confirmed with one of the IGRA
8.
Please answer the following:
Does your facility conduct any periodic (e.g. annual or other?) information sessions to
provide "basic information about TB" and to explain details about "employee TB
testing"?
Yes
No
Not sure
9.
Please answer the following:
Would outside assistance with a didactic session (e.g. annual) for employees providing
information about infectious diseases in the hospital setting (e.g. concerning
tuberculosis, influenza, hepatitis B, HIV, Ebola etc) be useful? Yes
No
10.

What is your hospital procedure if a staff member tests positive for TB?

11.
What additional comments, questions or suggestions do you have
concerning policies and training regarding infectious diseases of concern to
employees (e.g. influenza, hepatitis B etc) in general or regarding tuberculosis in
particular?
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APPENDIX B: PRELIMINARY HOSPITAL QUESTIONNAIRE
1. Which of these best describes your hospital's policy?
a) All hospital employees are tested annually
b) Employees are tested upon hire only
c) All employees are tested upon hire and annually thereafter
d) Annual testing is limited to specific departments or workers (check all that apply)
__Physicians
__Laboratory personnel
practitioners (NPs and Pas)

__Mid-level

__Nurses

__Maintenance or engineering staff __ Janitorial staff

__Administrators

__Transportation staff

__Contract staff

__Students

__Dietary staff
__Service personnel

__Construction or renovation staff
__Other (specify) _____________________________
2. Which test does your facility utilize for upon hire TB screening?
a) Two-step TST
b) Interferon Gamma Release Assay;
Which one:____________________________________
c) Symptom screen
3. Which test does your facility utilize for annual testing?
a) Two-step TST
b) Interferon Gamma Release Essay;
Which one:____________________________________
c) Symptom screen
4. How often are TB risk assessments conducted at this facility?
a) 1> year b) 1 per year c) 2 ≥ per year d) Facility does not conduct risk assessments
5. How often does this facility conduct training and education for employees regarding TB
with focus on prevention, transmission, and symptoms?
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a) 1> year
b) 1 per year
c) 2 ≥ per year
d) Facility does not conduct risk assessment
6. Does the facility utilize CDC's TB Risk Assessment Recommendations from MMWR
December 30, 2005 for TB policy guidelines?
a)Yes; Facility utilizes all of the recommendations.
b) Yes; Facility utilizes some of the recommendations.
c) Not Sure
d) No; Facility utilizes none of the recommendations.
7. If you answered No to the previous question, which best describes why your facility
does not utilize CDC's TB Risk Assessment Recommendations from MMWR December
30, 2005 for TB policy guidelines? (Check the one that best applies).
__Not helpful

__Cumbersome

__Cost ineffective

__Other (specify) ___________________________________________________
8. Have employees in your facility experienced conversion to TB disease among employees
who previously tested negative?
a)Yes
b) No
9. If you answered yes to Question 8, please indicate the following:
a) Number of Employees:_______________________________
b) Primary Test Used:___________________________________
c) Secondary Test Used:__________________________________
d) If second test is different from primary test, does your facility currently use the
secondary test now as its primary test? Please select:
______ YES _______NO;
why not?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
______________________________
10. What suggestions do you/your facility have in regards to controlling and preventing
M.Tuberculosis transmission in your facility?
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APPENDIX C: TB RISK ASSESSMENT WORKSHEET
This model worksheet should be considered for use in performing TB risk assessments
for healthcare facilities and nontraditional facility-based settings. Facilities with more
than one type of setting will need to apply this table to each setting.
Scoring √ or Y = Yes
X or N = No
NA = Not Applicable
1.
Incidence of TB
What is the incidence of TB in your community (county or region served by the healthcare setting), and how does it compare with the state and national average? What is the
incidence of TB in your facility and specific settings and how do those rates compare?
(Incidence is the number of TB cases in your community the previous year. A rate of TB
cases per 100,000 persons should be obtained for comparison.)* This information can be
obtained from the state or local health department.
Community rate_______
State rate ____________
National rate _________
Facility rate __________
Department 1 rate _______
Department 2 rate _______
Department 3 rate _______
Are patients with suspected or confirmed TB disease encountered in your setting
(inpatient and outpatient)? Yes
No
If yes, how many patients with suspected and confirmed TB disease are treated in your
health-care setting in 1 year (inpatient and outpatient)? Review laboratory data, infectioncontrol records, and databases containing discharge diagnoses. Year No. patients
Suspected Confirmed
1
year ago _____ _____
2
years ago _____ _____
5 years ago _____ _____
If no, does your health-care setting have a plan for the triage of patients with suspected
or confirmed TB disease? Yes
No
Currently, does your health-care setting have a cluster of persons with confirmed TB
disease that might be a result of ongoing transmission of
Mycobacterium tuberculosis within your setting (inpatient and outpatient)? Yes No
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2.
Risk Classification
Inpatient settings
How many inpatient beds are in your inpatient setting?
How many patients with TB disease are encountered in the inpatient setting in 1 year?
Review laboratory data, infection-control records, and databases containing discharge
diagnoses. Previous year ______ 5 years ago ______
Depending on the number of beds and TB patients encountered in 1 year, what is the risk
classification for your inpatient setting? (See Appendix C.)
ο Low risk ο Medium
risk ο Potential ongoing transmission
Does your health-care setting have a plan for the triage of patients with suspected or
confirmed TB disease?
Yes
No
Outpatient settings
How many TB patients are evaluated at your outpatient setting in 1 year? Review
laboratory data, infection-control records, and databases containing discharge diagnoses.
Previous year ______ 5 years ago ______
Is your health-care setting a TB clinic?
(If yes, a classification of at least medium risk is recommended.) Yes No
Does evidence exist that a high incidence of TB disease has been observed in the
community that the health-care setting serves?
Yes No
Does evidence exist of person-to-person transmission of M. tuberculosis in the healthcare setting? (Use information from case reports. Determine if any tuberculin skin test
[TST] or blood assay for M. tuberculosis [BAMT] conversions have occurred among
health-care workers [HCWs]).
Yes No
Does evidence exist that ongoing or unresolved health-care–associated Yes No
transmission has occurred in the health-care setting (based on case reports)?
Is there a high incidence of immunocompromised patients or HCWs in the health-care
setting?
Yes No
Have patients with drug-resistant TB disease been encountered in your healthcare setting
within the previous 5 years?
Yes No
Year ________
When was the first time a risk classification was done for your health-care setting?
__________________
Considering the items above, would your health-care setting need a higher risk
classification?
Yes No
Depending on the number of TB patients evaluated in 1 year, what is the risk classification
for your outpatient setting? (See Appendix C)
ο Low risk ο Medium risk ο Potential
ongoing transmission
Does your health-care setting have a plan for the triage of patients with suspected or
confirmed TB disease?
Yes
No
Nontraditional facility-based settings
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How many TB patients are encountered at your setting in 1 year? Previous year 5 years
ago ______ ______
Does evidence exist that a high incidence of TB disease has been observed in the
community that the setting serves? Yes No
Does evidence exist of person-to-person transmission of M. tuberculosis in the setting?
Yes No
Have any recent TST or BAMT conversions occurred among staff or clients? Yes No
Is there a high incidence of immunocompromised patients or HCWs in the setting?
Yes No
Have patients with drug-resistant TB disease been encountered in your healthcare setting
within the previous 5 years?
Yes No
Year ________
When was the first time a risk classification was done for your setting?
Considering the items above, would your setting require a higher risk classification?
Yes No
Does your setting have a plan for the triage of patients with suspected or confirmed TB
disease?
Yes
No
Depending on the number of patients with TB disease who are encountered in a
nontraditional setting in 1 year, what is the risk classification for your setting?
(See Appendix C) ο Low risk ο Medium risk ο Potential ongoing transmission
3.
Screening of HCWs for M. tuberculosis Infection
Does the health-care setting have a TB screening program for HCWs? Yes No
If yes, which HCWs are included in the TB screening program? (Check all that apply.) ο
Physicians
ο Mid-level practitioners (nurse practitioners [NP] and physician’s assistants [PA])
ο Nurses ο Administrators ο Laboratory workers ο Respiratory therapists
ο
Janitorial staff
ο Maintenance or engineering staff ο Transportation staff ο Dietary staff ο Receptionists
ο Trainees and students ο Volunteers
ο Others_________________
ο Physical therapists ο Contract staff
ο Construction or renovation workers ο Service workers
Is baseline skin testing performed with two-step TST for HCWs? Yes No
Is baseline testing performed with QFT or other BAMT for HCWs?
Yes No
How frequently are HCWs tested for M. tuberculosis infection?
Are the M. tuberculosis infection test records maintained for HCWs?
Yes No
Where are the M. tuberculosis infection test records for HCWs maintained? Who
maintains the records?
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If the setting has a serial TB screening program for HCWs to test for M. tuberculosis
infection, what are the conversion rates for the previous years? †
1
year ago _________________
4 years ago _________________
2
years ago _________________
5 years ago _________________
3
years ago _________________
Has the test conversion rate for M. tuberculosis infection been increasing or decreasing,
or has it remained the same over the previous 5 years? (check one)
ο Increasing ο
Decreasing ο No change
Do any areas of the health-care setting (e.g., waiting rooms or clinics) or any group of
HCWs (e.g., lab workers, emergency department staff, respiratory therapists, and HCWs
who attend bronchoscopies) have a test conversion rate for M. tuberculosis infection that
exceeds the health-care setting’s annual average? Yes No
If yes, list _________________________
_________________________________ _________________________________
For HCWs who have positive test results for M. tuberculosis infection and who leave
employment at the health setting, are efforts made to communicate test results and
recommend follow-up of latent TB infection (LTBI) treatment with the local health
department or their primary physician?
Yes No
Not applicable
4.
TB Infection-Control Program
Does the health-care setting have a written TB infection-control plan?
Y
es No
Who is responsible for the infection-control program?
When was the TB infection-control plan first written?
When was the TB infection-control plan last reviewed or updated?
Does the written infection-control plan need to be updated based on the timing of the
previous update (i.e., >1 year, changing TB epidemiology of the community or setting,
the occurrence of a TB outbreak, change in state or local TB policy, or other factors related
to a change in risk for transmission of M. tuberculosis)? Yes No
Does the health-care setting have an infection-control committee (or another committee
with infection control responsibilities)?
Yes No
If yes, which groups are represented on the infection-control
committee? (Check all that apply.) ο Laboratory personnel ο Physicians
ο
Health and safety staff ο Nurses
ο Administrator
ο Epidemiologists
ο Risk assessment ο Engineers
ο Quality control (QC)
ο Pharmacists
ο Others (specify)_________
If no, what committee is responsible for infection control in the setting?
5.
Implementation of TB Infection-Control Plan Based on Review by InfectionControl Committee
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Has a person been designated to be responsible for implementing an infection-control plan
in your health-care setting? If yes, list the name: _________________________ Yes No
Based on a review of the medical records, what is the average number of days for the
following:
•
Presentation of patient until collection of specimen _____
•
Specimen collection until receipt by laboratory
_____
•
Receipt of specimen by laboratory until smear results are provided to health-care
provider _____
•
Diagnosis until initiation of standard antituberculosis treatment
_____
•
Receipt of specimen by laboratory until culture results are provided to health-care
provider _____
•
Receipt of specimen by laboratory until drug-susceptibility results are provided to
health-care provider _____
•
Receipt of drug-susceptibility results until adjustment of antituberculosis treatment,
if indicated _____
•
Admission of patient to hospital until placement in airborne infection isolation (AII)
_____
Through what means (e.g., review of TST or BAMT conversion rates, patient medical
records, and time analysis) are lapses in infection control recognized?
What mechanisms are in place to correct lapses in infection control?
Based on measurement in routine QC exercises, is the infection-control plan being
properly implemented?
Yes No
Is ongoing training and education regarding TB infection control practices provided for
HCWs?
Yes No
Which environmental controls are in place in your health-care setting? (Check all that
apply and describe)
Environmental control
Description ο AII rooms
_____________________
6.
Laboratory Processing of TB-Related Specimens, Tests, and Results Based on
Laboratory Review
Which of the following tests are either conducted in-house at your healthcare setting’s
laboratory or sent out to a reference laboratory? In-house
Sent out
Acid-fast bacilli (AFB) smears
Culture using liquid media (e.g., Bactec and MB-BacT)
Culture using solid media
Drug-susceptibility testing
Nucleic acid amplification (NAA) testing
What is the usual transport time for specimens to reach the laboratory for the following
tests?
AFB smears ___________
Culture using liquid media (e.g., Bactec, MB-BacT)
___________
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Culture using solid media
___________
Drug-susceptibility testing ___________
Other (specify)
___________
NAA testing ___________
Does the laboratory at your health-care setting or the reference laboratory used by your
health-care setting report AFB smear results for all patients within 24 hours of receipt of
specimen? Yes No
What is the procedure for weekends?
7.

Environmental Controls

ο

Local exhaust ventilation (enclosing devices and exterior devices)
_____________________ ο General ventilation (e.g., single-pass system,
recirculation system.) _____________________
ο Air-cleaning methods (e.g., high-efficiency particulate air [HEPA] filtration and
ultraviolet
germicidal
irradiation
[UVGI])
___________________________________________________________
What are the actual air changes per hour (ACH) and design for various rooms in the
setting?
Room ACH Design
Which of the following local exterior or enclosing devices such as exhaust ventilation
devices are used in your health-care setting? (Check all that apply) ο Laboratory hoods ο
Booths for sputum induction
ο Tents or hoods for enclosing patient or procedure
What general ventilation systems are used in your health-care setting? (Check all that
apply) ο Single-pass system ο Variable air volume (VAV) ο Constant air volume (CAV)
ο Recirculation system ο Other____________________
What air-cleaning methods are used in your health-care setting? (Check all that apply)
HEPA filtration ο Fixed room-air recirculation systems ο Portable room-air recirculation
systems
UVGI
ο Duct irradiation ο Upper-air irradiation ο Portable room-air cleaners
How many AII rooms are in the health-care setting?
What ventilation methods are used for AII rooms? (Check all that apply) Primary (general
ventilation):
ο Single-pass heating, ventilating, and air conditioning (HVAC) ο Recirculating HVAC
systems
Secondary (methods to increase equivalent ACH):
ο Fixed room recirculating units ο HEPA filtration ο UVGI
ο Other (specify) _________________
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Does your health-care setting employ, have access to, or collaborate with an
environmental engineer (e.g., professional engineer) or other professional with
appropriate expertise (e.g., certified industrial hygienist) for consultation on design
specifications, installation, maintenance, and evaluation of environmental controls?
Yes No
Are environmental controls regularly checked and maintained with results recorded in
maintenance logs? Yes No
Are AII rooms checked daily for negative pressure when in use? Yes No
Is the directional airflow in AII rooms checked daily when in use with smoke tubes or
visual checks?
Yes No
Are these results readily available? Yes No
What procedures are in place if the AII room pressure is not negative?
______________________________________
Do AII rooms meet the recommended pressure differential of 0.01-inch water column
negative to surrounding structures? Yes No
8.
Respiratory-Protection Program
Does your health-care setting have a written respiratory-protection program?
Yes No
Which HCWs are included in the respiratory protection program? (Check all that apply)
ο Physicians
ο Mid-level practitioners (NPs and PAs) ο Nurses ο Administrators ο Laboratory
personnel
ο Contract staff
ο Construction or renovation staff ο Service personnel
ο Janitorial staff
ο Maintenance or engineering staff
ο Transportation staff ο Dietary staff ο Students
ο Others (specify)_____________ ___________________________
Are respirators used in this setting for HCWs working with TB patients? If yes, include
m model, and specific application (e.g., ABC model 1234 for bronchoscopy and DEF
model contact with infectious TB patients).
Manufacturer Model
Specific application Manufacturer,
5678
for
routine
Is annual respiratory-protection training for HCWs performed by a person with advanced
training in respiratory protection? Yes No
Does your health-care setting provide initial fit testing for HCWs? If yes, when is it
conducted? ____________________________
Yes No
Does your health-care setting provide periodic fit testing for HCWs?
If yes, when and how frequently is it conducted? ____________________________
Yes No
What method of fit testing is used? Describe.
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Is qualitative fit testing used?
Yes No
Is quantitative fit testing used?
Yes No
9. Reassessment of TB risk
How frequently is the TB risk assessment conducted or updated in the health-care setting?
When was the last TB risk assessment conducted?
What problems were identified during the previous TB risk assessment?
What actions were taken to address the problems identified during the previous TB risk
assessment?
Did the risk classification need to be revised as a result of the last TB risk assessment?
Yes No
*
If the population served by the health-care facility is not representative of the
community in which the facility is located, an alternate comparison population might be
appropriate.
†
Test conversion rate is calculated by dividing the number of conversions among
HCWs by the number of HCWs who were tested and had prior negative results during a
certain period (see Supplement, Surveillance and Detection of M. tuberculosis infections
in Health-Care Settings).
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APPENDIX D: TUBERCULOSIS BASELINE PERSONNEL ASSESSMENT
BOX. Indicators of risk* for tuberculosis (TB) at baseline health care personnel assessment†
Health care personnel should be considered to be at increased risk for TB if they answer “yes” to
any of the following statements.
1. Temporary or permanent residence (for ≥1 month) in a country with a high TB rate (i.e., any
country other than Australia, Canada, New Zealand, the United States, and those in western or
northern Europe)
Or
2. Current or planned immunosuppression, including human immunodeficiency virus infection,
receipt of an organ transplant, treatment with a TNF-alpha antagonist (e.g., infliximab,
etanercept, or other), chronic steroids (equivalent of prednisone ≥15 mg/day for ≥1 month), or
other immunosuppressive medication
Or
3. Close contact with someone who has had infectious TB disease since the last TB test
Abbreviation: TNF = tumor necrosis factor.
* Individual risk assessment information can be useful in interpreting TB test results. Lewinsohn
DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society
of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of
tuberculosis
in
adults
and
children.
Clin
Infec
Dis
2017;64:111–5).
https://academic.oup.com/cid/article/64/2/111/2811357external icon
† Adapted from a tuberculosis risk assessment form developed by the California Department of
Public
Health.
https://www.cdph.ca.gov/Programs/CID/DCDC/CDPH%20Document%20Library/TBCB-CA-TBRisk-Assessment-and-Fact-Sheet.pdfpdf iconexternal icon.
Suggested citation for this article: Sosa LE, Njie GJ, Lobato MN, et al. Tuberculosis Screening,
Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National
Tuberculosis Controllers Association and CDC, 2019. MMWR Morb Mortal Wkly Rep 2019;
68:439–443. DOI: http://dx.doi.org/10.15585/mmwr.mm6819a3external icon.

38

